Bacillus sphaericus is a sporeforming bacterium with a high degree of insecticidal activity toward larvae of certain mosquito species. This bacterium is being developed as a microbial control agent for use in integrated vector control programs. Among the nearly 40 insecticidal strains of B. sphaericus currently known two very similar strains, 1593 and 2362, appear to have the greatest potential utility. Bacillus sphaericus 1593 kills mosquito larvae by means of a protein toxin of ca. 50 Kdal, which is produced during sporulation. This toxin is packaged in a parasporal crystal and to a lesser extent in the spore itself. Intoxicated larvae show gut and behavioral symptoms within 1 hr of ingestion of large dose of B. sphaericus, and may die in as little as 4 hr. The objectives of this proposal are to develop an invitro assay for the B. sphaericus toxin utilizing cultured mosquito cells and to use this assay to investigate parameters of the host-pathogen interaction including toxin activation, binding, and molecular mode of action, as well as ultrastructural changes in the cells. Toxin will be purified using a combination of gel and ion exchange chromatography, possibly followed by affinity or HPLC chromatography. Monoclonal and polyclonal antibodies raised to the toxin will be utilized in purification and localization of the toxin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022702-02
Application #
3134193
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1985-09-01
Project End
1988-02-29
Budget Start
1986-09-01
Budget End
1988-02-29
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Arizona State University-Tempe Campus
Department
Type
Schools of Arts and Sciences
DUNS #
188435911
City
Tempe
State
AZ
Country
United States
Zip Code
85287
Berry, C; Hindley, J; Ehrhardt, A F et al. (1993) Genetic determinants of host ranges of Bacillus sphaericus mosquito larvicidal toxins. J Bacteriol 175:510-8
Davidson, E W; Oei, C; Meyer, M et al. (1990) Interaction of the Bacillus sphaericus mosquito larvicidal proteins. Can J Microbiol 36:870-8
Schroeder, J M; Chamberlain, C; Davidson, E W (1989) Resistance to the Bacillus sphaericus toxin in cultured mosquito cells. In Vitro Cell Dev Biol 25:887-91
Chin, Y H; Falanga, V; Streilein, J W et al. (1989) Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction. J Invest Dermatol 93:82S-87S
Davidson, E W (1989) Variation in binding of Bacillus sphaericus toxin and wheat germ agglutinin to larval midgut cells of six species of mosquitoes. J Invertebr Pathol 53:251-9
Sackstein, R; Falanga, V; Streilein, J W et al. (1988) Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J Invest Dermatol 91:423-8
Davidson, E W; Titus, M (1987) Ultrastructural effects of the Bacillus sphaericus mosquito larvicidal toxin on cultured mosquito cells. J Invertebr Pathol 50:213-20
Davidson, E W; Bieber, A L; Meyer, M et al. (1987) Enzymatic activation of the Bacillus sphaericus mosquito larvicidal toxin. J Invertebr Pathol 50:40-4
Davidson, E W; Shellabarger, C; Meyer, M et al. (1987) Binding of the Bacillus sphaericus mosquito larvicidal toxin to cultured insect cells. Can J Microbiol 33:982-9